1
/
of
0
FDA Drug Approval, N020591, TARKA
FDA Drug Approval, N020591, TARKA
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 020591
Company: ABBVIE
Drug Name: TARKA
Active Ingredients: TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE
Strength: 2MG;240MG
Dosage Form/Route: TABLET, EXTENDED RELEASE;ORAL
Action Date: 10/22/1996
Marketing Status: Discontinued
Submission Classification: Type 4 - New Combination
Company: ABBVIE
Drug Name: TARKA
Active Ingredients: TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE
Strength: 2MG;240MG
Dosage Form/Route: TABLET, EXTENDED RELEASE;ORAL
Action Date: 10/22/1996
Marketing Status: Discontinued
Submission Classification: Type 4 - New Combination
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details